Oxford BioMedica in cancer deal with Virbac

Oxford BioMedica (LSE:OXB) and Virbac (Paris, France) will develop and market OXB's cancer vaccine technology for pets using OXB's pox-virus delivery system. Virbac will make upfront and milestone pay...